Navigation Links
Jubilant HollisterStier Allergy Launches 'Allergy Industry Insights' Educational Webinar Series
Date:8/31/2011

SPOKANE, Wash., Aug. 31, 2011 /PRNewswire/ -- HollisterStier Allergy, a division of Jubilant HollisterStier, is expanding their educational offerings for customers with the launch of Allergy Industry Insights, a series of free webinars for the allergist community. The webinars will serve as educational tools allergists can use to stay on top of developing trends and more effectively manage their practices.

The webinars will focus on relevant industry topics such as skin testing, reimbursement, and electronic medical records. Larry Garner, HollisterStier Allergy's National Allergy Consultant and well-known lecturer on allergy immunotherapy and dosing, will be hosting the webinars.

"These webinars will allow us the opportunity to educate and interact with a broader range of the allergy community," said Garner. "We are working to assist allergists in improving patients' lives and enhancing their practices by educating them on relevant industry topics."

The webinar series joins the Company's extensive collection of no-cost educational offerings for healthcare professionals, such as the Bee Aware Program launched recently by HollisterStier Allergy to educate emergency department personnel about stinging insect allergies and treatments.

The first webinar in the series will focus on Skin Testing and Diagnostic Guidelines and will be held August 31st.  Subsequent webinars will be held quarterly. Allergists will be able to register for the webinars and access previously recorded installments online, through the HollisterStier Allergy website.

About Jubilant HollisterStier's Allergy Division

Jubilant HollisterStier's Allergy Division is a leading manufacturer of high-quality allergy products for the global market. The organization provides a complete line of products for the testing and treatment of allergies. Its product portfolio includes many exclusive products, such as the Acetone Precipitated (AP)™ line of extracts and a complete line of skin testing devices including QUINTIP® and ComforTen®.  Jubilant HollisterStier, located in Spokane, Washington,  is a subsidiary of  Jubilant Life Sciences Ltd., an integrated pharma and Life Sciences player, headquartered in India.  Jubilant HollisterStier is engaged in offering contract manufacturing services for sterile and non sterile products through its contract manufacturing & services division as well as providing Allergy products through the Allergy Division.  

For more information visit www.HSallergy.com.  For more information on the Bee Aware Program visit www.BeeAwareAllergy.org.

About Jubilant Life Sciences

Jubilant Life Sciences Limited is an integrated Pharma and Life Sciences Company.  It is the largest Custom Research and Manufacturing Services (CRAMS) Company and a leading Drug Discovery & Development Solutions provider out of India. The Company provides Life Sciences products and services across the value chain.  With 10 world-class manufacturing facilities and a team of ~5700 multicultural people across the globe, the Company is committed to deliver value to its customers spread in over 70 countries. The Company is well recognized as a "Partner of Choice" by leading life sciences companies worldwide.

For more information visit www.jubl.com

INQUIRIES:
Alison Marlin
509.951.0165
amarlin@jhs.jubl.com


'/>"/>
SOURCE Jubilant HollisterStier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Jubilant Enters Research Collaboration With AstraZeneca
2. Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture
3. Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery
4. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
5. Study Says Allergy Shots Help Children, Reduce Health Care Costs
6. American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast
7. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
8. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
9. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
10. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
11. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ALEX , has taken Kickstarter by storm, crowdfunding over $60,000 – or 120% of its original ... to be delivered to backers starting May of this year. ... ... ... Created by NAMU, a team of biomedical engineers out of ...
(Date:2/11/2016)... ROLLING MEADOWS , Ill. and INDIANAPOLIS ... major milestone for many young people, but for those ... demanding. Not only do these students juggle class schedules, ... challenges of living with type 1 diabetes. On top ... the first time. Diabetes Scholars Foundation ...
(Date:2/11/2016)... Feb. 11, 2016  AbbVie, a global biopharmaceutical ... Scholarship, designed to provide financial support for exceptional ... pursue higher education goals. Fifteen scholars will be ... school year. The AbbVie Rheumatology Scholarship is currently ... vice president, corporate social responsibility, brand and communications, ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 12, 2016 , ... The Journal ... up from 0.416 in 2013. The SJR uses data taken from the Scopus database ... both the number of citations received by the journal over a three year period ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health and ... for their simultaneous grand openings in March. All seven practices are set to ... wondering, is reversing diabetes possible? According to this 2011 CNN article it is ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans and ... health care system that’s partnering with Intel on value-based health benefits program Connected ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
(Date:2/11/2016)... Long Island, NY (PRWEB) , ... February 11, ... ... (INS) has enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, ... global leader in vein illumination with an estimated 85% share of the market, ...
Breaking Medicine News(10 mins):